Role of Taxotere in metastatic castration-resistant prostate cancer in Sudanese patients and the effective number of cycle and dose (2013–2017)

El-Nazir, Ehssan Mohamed; Suleiman, Yousra Abdelmoniem; Alameen, Rogia Omer Ibrahim; Abaker, Khalda Esmaiel Adam; Mohammed, Rayan Mohammed Yassin; Al-Rayah, Anfal Abd-Alrhman; Alzain, Thowiba Abd-Alrahman; Alrayah, Alaa Albukhari; Mohammed, Sujood Abd Elmoneim; Elgasim, Mawahib Ahmed Elawad Abu; Babker, Roaa Osman Ahmed

doi:10.7861/clinmedicine.19-3s-s31

Clinical Medicine

2019

DOI: 10.7861/clinmedicine.19-3s-s31

|View full text |Cite

Role of Taxotere in metastatic castration-resistant prostate cancer in Sudanese patients and the effective number of cycle and dose (2013–2017)

Ehssan Mohamed El-Nazir

Yousra Abdelmoniem Suleiman

Rogia Omer Ibrahim Alameen

et al.

Abstract: prostate-specific antigen (PSA) response and pain. According to this study we found that docetaxel has an effective role in the treatment of mCRPC patients with an optimal number of 6-8 cycles every 3 weeks and with a dose of 75 mg. ■ Conflict of interest statement None declared.

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Role of Taxotere in metastatic castration-resistant prostate cancer in Sudanese patients and the effective number of cycle and dose (2013–2017)

Abstract: prostate-specific antigen (PSA) response and pain. According to this study we found that docetaxel has an effective role in the treatment of mCRPC patients with an optimal number of 6-8 cycles every 3 weeks and with a dose of 75 mg. ■ Conflict of interest statement None declared.

This publication either has no citations yet, or we are still processing them

See others like this or search for similar articles

Contact Info

Product

Resources

About